Clinical Trial Update: MMP-9 Inhibition for Recalcitrant Wet AMD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating inhibitors of MMP-9 for recalcitrant wet age-related macular degeneration; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wet Age-related Macular Degeneration

Drugs mentioned

• MMP-9 inhibitor (trial agent)

Snippet

Sponsor: University of Iowa | Conditions: Exudative Macular Degeneration, Wet Age-related Macular Degeneration | Phase 2 | Status: RECRUITING